Top Markets
Coin of the day
Viveon Health Acquisition Corp. Viveon Health Acquisition Corp.

Viveon Health Acquisition Corp.

VHAQ
Rank in Stocks #23984
Viveon Health Acquisition Corp. presently lacks substantial ongoing operations.... Viveon Health Acquisition Corp. presently lacks substantial ongoing operations. The company's main goal is to finalize a strategic transaction, which could include a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or a similar business combination, involving one or more companies in the North American healthcare industry. This firm was established in 2020 and is headquartered in Norcross, Georgia.
Share Price
$10.00
Last synced: 2025-01-30
Market Cap
$66.49M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Viveon Health Acquisition Corp. (VHAQ)
P/E ratio for Viveon Health Acquisition Corp. (VHAQ)
P/E ratio as of 2026 TTM: 0
According to Viveon Health Acquisition Corp. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Viveon Health Acquisition Corp. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.